Drugs / Flamboyant 125/12
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04191434 | Jul 2022 → May 2023 | asthma | EMS | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flamboyant 125/12 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04191434 ↗ |
| Route | Inhaled | “The participant must inhale 2 (two) capsules twice a day (12/12h)” NCT04191434 ↗ |